000 01238 a2200373 4500
005 20250512092805.0
264 0 _c19680826
008 196808s 0 0 eng d
022 _a0041-1132
024 7 _a10.1111/j.1537-2995.1968.tb04889.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRosenfield, R E
245 0 0 _aImmunologic suppression of primary Rh antibody formation.
_h[electronic resource]
260 _bTransfusion
_c
300 _a125-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aErythroblastosis, Fetal
_xprevention & control
650 0 4 _aFemale
650 0 4 _aHemagglutination Tests
650 0 4 _aHumans
650 0 4 _aImmunity, Active
650 0 4 _aImmunity, Maternally-Acquired
650 0 4 _aImmunization
650 0 4 _aIodine Isotopes
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Hematologic
_xprevention & control
650 0 4 _aRabbits
650 0 4 _aRh-Hr Blood-Group System
650 0 4 _agamma-Globulins
_xtherapeutic use
773 0 _tTransfusion
_gvol. 8
_gno. 3
_gp. 125-6
856 4 0 _uhttps://doi.org/10.1111/j.1537-2995.1968.tb04889.x
_zAvailable from publisher's website
999 _c4178771
_d4178771